Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
暂无分享,去创建一个
Emma Hall | Kevin J Harrington | S. Bhide | K. Harrington | C. Clark | E. Miles | R. A’Hern | C. Nutting | E. Hall | A. Miah | K. Newbold | J. Morden | S. Jefferies | C. Scrase | Shreerang A Bhide | Christopher M Nutting | Sarah J Jefferies | B. Yap | F. Adab | Kate Newbold | Marie Emson | James P Morden | Mark A Sydenham | Christopher Scrase | M. Sydenham | T. G. Urbano | M. Tanay | M. Emson | Elizabeth A Miles | Catharine Clark | Teresa Guerrero Urbano | Aisha B Miah | MaryAnne Tanay | Fawzi Adab | Beng K Yap | Roger P A'Hern
[1] C. Tsien,et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. , 2005, International journal of radiation oncology, biology, physics.
[2] Johannes A Langendijk,et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. , 2009, International journal of radiation oncology, biology, physics.
[3] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[4] R. Henriksson,et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. , 1992, European journal of cancer.
[5] H. Bartelink,et al. EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. , 1995, International journal of radiation oncology, biology, physics.
[6] Tai-Lin Huang,et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. , 2008, International journal of radiation oncology, biology, physics.
[7] J. Sham,et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.
[8] Andrew Bottomley,et al. EORTC QLQ-C30 Scoring Manual , 1995 .
[9] C H Clark,et al. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. , 2009, The British journal of radiology.
[10] J. Bourhis,et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. , 2007, International journal of radiation oncology, biology, physics.
[11] L. Bastholt,et al. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. , 1994, Acta oncologica.
[12] G. Terhaar,et al. Heating techniques in hyperthermia. III. Ultrasound. , 1981 .
[13] J. Hanson,et al. Correlation Between Saliva Production and Quality of Life Measurements in Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy , 2007, American journal of clinical oncology.
[14] C. Nutting,et al. Clinical use of intensity-modulated radiotherapy: part II. , 2004, The British journal of radiology.
[15] P. Rubin,et al. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. , 1995, International journal of radiation oncology, biology, physics.
[16] S. Bhide,et al. Dosimetry audit for a multi-centre IMRT head and neck trial. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] D A Low,et al. Intensity‐modulated radiation therapy in head and neck cancers: The Mallinckrodt experience , 2000, International journal of cancer.
[18] R K Ten Haken,et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. , 1999, Acta oto-rhino-laryngologica Belgica.
[19] 豊 木村,et al. 胃癌手術におけるCommon Terminology Criteria for Adverse Events v3.0を利用した合併症の評価 , 2009 .
[20] S. Leung,et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] S. Kaasa,et al. Psychological distress in head and neck cancer patients 7-11 years after curative treatment. , 1995, British Journal of Cancer.
[22] A. Eisbruch,et al. The influence of pre-radiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers. , 1998, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[23] N. Slevin,et al. Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[26] F. Fang,et al. Intensity‐modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma , 2007, Cancer.
[27] G. Field,et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.
[28] K. Harrington,et al. Evidence-based review: quality of life following head and neck intensity-modulated radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[30] S. Kaasa,et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. , 1994, Acta oncologica.
[31] J. Pignon,et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] D. Dearnaley,et al. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[33] J. Sham,et al. Preservation of quality of life after intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma: Results of a prospective longitudinal study , 2006, Head & neck.
[34] M Van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.
[35] D P Dearnaley,et al. Intensity modulated radiation therapy: a clinical review. , 2000, The British journal of radiology.
[36] M. Martel,et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. , 1996, International journal of radiation oncology, biology, physics.
[37] Jacques Bernier,et al. Late effects toxicity scoring: the SOMA scale , 1995 .
[38] M K Martel,et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. , 2000, International journal of radiation oncology, biology, physics.
[39] P. Levendag,et al. Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long‐term survivors , 2002, Head & neck.
[40] A. Eisbruch,et al. Parotid Sparing Study in Head and Neck Cancer Patients Receiving Bilateral Radiation Therapy: One-year Results , 1997, Journal of dental research.
[41] M. Martel,et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. , 1998, International journal of radiation oncology, biology, physics.